g-Nostics Announces Award of Key Patent in Europe for Production of Patch Formulations of Generic Drugs
News May 05, 2010
g-Nostics Ltd, the personalized medicine company, announces the award of a key patent for the production of patch formulations which g-Nostics will apply to the manufacturing of low cost generic drug patch formulations with their joint venture partner in Beijing for both the domestic Chinese market and for export to other markets.
The transdermal production patent which g-Nostics holds under exclusive license from Transdermal Technologies & Systems Ltd (Windsor, UK) will allow g-Nostics to capitalize on its position as a leader in the Companion Diagnostic (CDx) market in smoking cessation by bringing the treatment together with the diagnostic to optimize both cost and clinical effectiveness in one of the world's largest therapeutic markets.
The first CDx product is a range of patches delivering nicotine over both 16hrs and 24hrs and is bio-equivalent to standard 'low' doses found on 'Over the Counter' shelves across Europe and the USA up to 63mg/24hrs.
A full range of Nicotine Replacement Therapy (NRT) patches allows the proprietary NicoTest® diagnostic to identify optimum treatment and dosing regimes to ensure the healthcare professional can selectively prescribe treatment on an individual basis to maximize the prospect of a positive clinical outcome.
The patent has been granted in Europe and was published on 28th April 2010 in the EPO's official bulletin as patent no 1755954.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018